These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1419299)

  • 1. Biological characterisation of primary and metachronous lesions in breast cancer patients.
    Silvestrini R; Valentinis B; Daidone MG; Di Fronzo G; Coradini D; Salvadori B
    Eur J Cancer; 1992; 28A(12):2006-10. PubMed ID: 1419299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.
    Silvestrini R; Daidone MG; Del Bino G; Mastore M; Luisi A; Di Fronzo G; Boracchi P
    Ann Oncol; 1993 Mar; 4(3):213-9. PubMed ID: 8471553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.
    Silvestrini R; Daidone MG; Mastore M; Di Fronzo G; Coradini D; Boracchi P; Squicciarini P; Salvadori B; Veronesi U
    J Clin Oncol; 1993 Jun; 11(6):1150-5. PubMed ID: 8501501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers.
    Collecchi P; Baldini E; Giannessi P; Naccarato AG; Passoni A; Gardin G; Roncella M; Evangelista G; Bevilacqua G; Conte PF
    Eur J Cancer; 1998 Oct; 34(11):1701-4. PubMed ID: 9893655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
    Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
    Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients.
    Valentinis B; Silvestrini R; Daidone MG; Coradini D; Galante E; Cerrotta AM; Abolafio G; Arboit L
    Breast Cancer Res Treat; 1991 Dec; 20(1):19-24. PubMed ID: 1813066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
    Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
    Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.
    Silvestrini R; Daidone MG; Luisi A; Boracchi P; Mezzetti M; Di Fronzo G; Andreola S; Salvadori B; Veronesi U
    J Clin Oncol; 1995 Mar; 13(3):697-704. PubMed ID: 7884430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible test for selection of adjuvant systemic therapy in early cancer of the breast.
    Cooke T; George WD; Griffiths K
    Br J Surg; 1980 Oct; 67(10):747-50. PubMed ID: 7427030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral breast cancer: differential diagnosis using histological and biological parameters.
    Gong SJ; Rha SY; Jeung HC; Roh JK; Yang WI; Chung HC
    Jpn J Clin Oncol; 2007 Jul; 37(7):487-92. PubMed ID: 17673471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant expression of hormone receptors and HER2 in breast cancer. A retrospective comparison of primary tumors with paired metachronous recurrences or metastases.
    Arapantoni-Dadioti P; Valavanis C; Gavressea T; Tzaida O; Trihia H; Lekka I
    J BUON; 2012; 17(2):277-83. PubMed ID: 22740206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in biological markers after primary chemotherapy for breast cancers.
    Daidone MG; Silvestrini R; Luisi A; Mastore M; Benini E; Veneroni S; Brambilla C; Ferrari L; Greco M; Andreola S
    Int J Cancer; 1995 May; 61(3):301-5. PubMed ID: 7729938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetics and hormonal features in relation to pathological stage in breast cancer.
    Amadori D; Bonaguri C; Nanni O; Gentilini P; Lundi N; Zoli W; Riccobon A; Vio A; Magni E; Saragoni A
    Breast Cancer Res Treat; 1991 Mar; 18(1):19-25. PubMed ID: 1854976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological correlation between HER-2/neu and proliferative activity in human breast cancer.
    Tommasi S; Paradiso A; Mangia A; Barletta A; Simone G; Slamon DJ; De Lena M
    Anticancer Res; 1991; 11(4):1395-400. PubMed ID: 1684096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor characteristics of the second tumor in synchronous versus metachronous breast cancer.
    Bu-Ali H; Solh M; Kapur A; Mittal V
    Am Surg; 2008 Aug; 74(8):702-5; discussion 706. PubMed ID: 18705570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma.
    Raabe NK; Hagen S; Haug E; Fossaa SD
    Int J Oncol; 1998 May; 12(5):1091-6. PubMed ID: 9538134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
    Balleine RL; Earl MJ; Greenberg ML; Clarke CL
    Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.